CA3265882A1 - Methods and compositions for hydrodynamic gene delivery - Google Patents
Methods and compositions for hydrodynamic gene deliveryInfo
- Publication number
- CA3265882A1 CA3265882A1 CA3265882A CA3265882A CA3265882A1 CA 3265882 A1 CA3265882 A1 CA 3265882A1 CA 3265882 A CA3265882 A CA 3265882A CA 3265882 A CA3265882 A CA 3265882A CA 3265882 A1 CA3265882 A1 CA 3265882A1
- Authority
- CA
- Canada
- Prior art keywords
- compositions
- methods
- gene delivery
- hydrodynamic gene
- hydrodynamic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263374216P | 2022-08-31 | 2022-08-31 | |
| US202263374234P | 2022-08-31 | 2022-08-31 | |
| US202263374231P | 2022-08-31 | 2022-08-31 | |
| US202263374058P | 2022-08-31 | 2022-08-31 | |
| US202263374070P | 2022-08-31 | 2022-08-31 | |
| US202263374073P | 2022-08-31 | 2022-08-31 | |
| US202263374228P | 2022-08-31 | 2022-08-31 | |
| US63/374,073 | 2022-08-31 | ||
| US63/374,070 | 2022-08-31 | ||
| US63/374,058 | 2022-08-31 | ||
| US63/374,231 | 2022-08-31 | ||
| US63/374,228 | 2022-08-31 | ||
| US63/374,234 | 2022-08-31 | ||
| US63/374,216 | 2022-08-31 | ||
| PCT/US2023/031751 WO2024050039A2 (en) | 2022-08-31 | 2023-08-31 | Methods and compositions for hydrodynamic gene delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3265882A1 true CA3265882A1 (en) | 2024-03-07 |
Family
ID=90098626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3265882A Pending CA3265882A1 (en) | 2022-08-31 | 2023-08-31 | Methods and compositions for hydrodynamic gene delivery |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4580685A2 (en) |
| JP (1) | JP2025529195A (en) |
| CN (1) | CN120166940A (en) |
| AU (1) | AU2023333051A1 (en) |
| CA (1) | CA3265882A1 (en) |
| WO (1) | WO2024050039A2 (en) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0406728D0 (en) * | 2004-03-25 | 2004-04-28 | Hydrodynamic Gene Delivery Ltd | Gene therapy |
| EP1853160A1 (en) * | 2005-02-28 | 2007-11-14 | Jan Malm | Method and device for determining the hydrodynamics of the cerebrospinal fluid system |
| US8915399B1 (en) * | 2012-11-06 | 2014-12-23 | Acist Medical Systems, Inc. | Simulated contrast injection medium |
| AU2014311994A1 (en) * | 2013-08-30 | 2016-04-21 | Indiana University Research & Technology Corporation | Hydrodynamic method and apparatus for delivering fluids to kidney tissues |
| US20170015994A1 (en) * | 2014-02-24 | 2017-01-19 | Massachusetts Institute Of Technology | Methods for in vivo genome editing |
| PE20231949A1 (en) * | 2015-10-30 | 2023-12-05 | Spark Therapeutics Inc | VARIANTS OF FACTOR VIII REDUCED WITH CpG, COMPOSITIONS AND METHODS AND USES FOR THE TREATMENT OF HEMOSTASY DISORDERS |
| US20200345867A1 (en) * | 2019-04-30 | 2020-11-05 | The Johns Hopkins University | Organ directed gene delivery |
| CA3213123A1 (en) * | 2021-03-25 | 2022-09-29 | Robert L. Kruse | Hydrodynamic gene delivery |
-
2023
- 2023-08-31 CN CN202380076280.1A patent/CN120166940A/en active Pending
- 2023-08-31 CA CA3265882A patent/CA3265882A1/en active Pending
- 2023-08-31 AU AU2023333051A patent/AU2023333051A1/en active Pending
- 2023-08-31 EP EP23861314.5A patent/EP4580685A2/en active Pending
- 2023-08-31 JP JP2025512908A patent/JP2025529195A/en active Pending
- 2023-08-31 WO PCT/US2023/031751 patent/WO2024050039A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN120166940A (en) | 2025-06-17 |
| WO2024050039A2 (en) | 2024-03-07 |
| WO2024050039A3 (en) | 2024-04-11 |
| AU2023333051A1 (en) | 2025-03-20 |
| JP2025529195A (en) | 2025-09-04 |
| EP4580685A2 (en) | 2025-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4114939A4 (en) | Oligonucleotide compositions and methods thereof | |
| CA3255116A1 (en) | mRNA Delivery Method and Composition Thereof | |
| CA3263935A1 (en) | Oligonucleotide compositions and methods thereof | |
| EP4175949A4 (en) | Methods and compositions for targeting tregs using ccr8 inhibitors | |
| AU2021413753A9 (en) | Compositions and methods for delivery of rna | |
| CA3265882A1 (en) | Methods and compositions for hydrodynamic gene delivery | |
| IL288542A (en) | Methods and compositions for microbial delivery of double stranded rna | |
| WO2022081738A3 (en) | Polymer-conjugated microbubbles for high drug/gene loading | |
| AU2024255035A1 (en) | Methods and compositions for targeted delivery by polymersomes | |
| HK40101750A (en) | Compositions and methods for delivery of rna | |
| CA3266104A1 (en) | Compositions and methods for delivery of rna | |
| EP4312805A4 (en) | Image guided delivery of compositions and related methods | |
| HK40099690A (en) | Compositions and methods for delivery of rna | |
| CA3288991A1 (en) | Compositions and methods for gene therapies | |
| HK40072477A (en) | Methods and compositions for microbial delivery of double stranded rna | |
| HK40097579A (en) | Compositions and methods for inhibiting gene expression | |
| HK40082433A (en) | Compositions and methods for inhibiting marc1 gene expression | |
| AU2023900463A0 (en) | Methods and compositions for gene editing | |
| HK40102528A (en) | Protoparvovirus and tetraparvovirus compositions and methods for gene therapy | |
| HK40112368A (en) | Compositions and methods for targeted rna delivery | |
| HK40094627A (en) | Compositions and methods for gene editing | |
| HK40125997A (en) | Oligonucleotide compositions and methods thereof | |
| HK40123943A (en) | Oligonucleotide compositions and methods thereof | |
| CA3251926A1 (en) | Oligonucleotide compositions and methods thereof | |
| HK40121869A (en) | Oligonucleotide compositions and methods relating thereto |